{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:15:12Z","timestamp":1767140112625,"version":"build-2238731810"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Medical Research Fund of P\u00e4ij\u00e4t-H\u00e4me Central District Hospital.","award":["no number"],"award-info":[{"award-number":["no number"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10067-019-04702-2","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T07:02:36Z","timestamp":1564038156000},"page":"263-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Trends towards more active introduction of drug therapy, emphasizing methotrexate and biologic agents, for juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3413-5459","authenticated-orcid":false,"given":"Heini","family":"Pohjankoski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Kautiainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhani Virta","family":"Lauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Puolakka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vappu","family":"Rantalaiho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"4702_CR1","first-page":"2275","volume":"30","author":"L Berntson","year":"2003","unstructured":"Berntson L, Andersson G\u00e4re B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, Marhaug G, Nielsen S, Pelkonen P, Rygg M, Nordic Study Group (2003) Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol 30:2275\u20132282","journal-title":"J Rheumatol"},{"key":"4702_CR2","first-page":"819","volume":"77","author":"A Ravelli","year":"2018","unstructured":"Ravelli A, Consolaro A, Horneff G, Laxer RM, Lovell DJ, Wulffraat NM, Akikusa JD, al-Mayouf SM, Ant\u00f3n J, Avcin T, Berard RA, Beresford MW, Burgos-Vargas R, Cimaz R, de Benedetti F, Demirkaya E, Foell D, Itoh Y, Lahdenne P, Morgan EM, Quartier P, Ruperto N, Russo R, Saad-Magalh\u00e3es C, Sawhney S, Scott C, Shenoi S, Swart JF, Uziel Y, Vastert SJ, Smolen JS (2018) Treating juvenile idiopathic arthritis to target: recommendations of an international task force. Ann Rheum Dis 77:819\u2013828","journal-title":"Ann Rheum Dis"},{"key":"4702_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/art.24087","volume":"61","author":"HM Albers","year":"2009","unstructured":"Albers HM, Wessels JAM, van der Straaten RJHM, Brinkman DMC, Suijlekom-Smit LWA, Kamphuis SSM, Girschick HJ, Wouters C, Schilham MW, le Cessie S, Huizinga TW, ten Cate R, Guchelaar HJ (2009) Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Arthritis Rheum 61:46\u201351","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4702_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, EM DW et al (2011) 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken) 63(4):465\u2013482. \nhttps:\/\/doi.org\/10.1002\/acr.20460","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"4702_CR5","doi-asserted-by":"publisher","first-page":"e000074","DOI":"10.1136\/rmdopen-2015-00074","volume":"1","author":"C Sengler","year":"2015","unstructured":"Sengler C, Klotsche J, Niewerth M, Liedman I, F\u00f6ll D, Heiligenhaus A et al (2015) The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from German inception. Rheumatic Musculoskelet Dis 1:e000074. \nhttps:\/\/doi.org\/10.1136\/rmdopen-2015-00074","journal-title":"Rheumatic Musculoskelet Dis"},{"key":"4702_CR6","first-page":"878","volume":"29","author":"H Pohjankoski","year":"2011","unstructured":"Pohjankoski H, Latva K, Kautiainen H, S\u00e4il\u00e4 H, Klaukka T, Virta L, Puolakka K, Pohjolainen T, Savolainen A (2011) First-year purchases of disease modifying drugs of incident patients with chronic juvenile arthritis in Finland. Clin Exp Rheumatol 29:878\u2013881","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"4702_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.jpeds.2013.03.047","volume":"163","author":"C Papadopoulou","year":"2013","unstructured":"Papadopoulou C, Kostik M, B\u00f6hm M, Nieto-Gonzalez JC, Gonzalez-Fernandez MI, Pistorio A, Martini A, Ravelli A (2013) Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis. J Pediatr 163(3):879\u2013884. \nhttps:\/\/doi.org\/10.1016\/j.jpeds.2013.03.047","journal-title":"J Pediatr"},{"issue":"4","key":"4702_CR8","first-page":"714","volume":"34","author":"MM Kostik","year":"2016","unstructured":"Kostik MM, Gaidar EV, Hynnes AY, Dubko MF, Masalova VY, Snegireva LS, Chikova IA, Isupova EA, Nikitina TN, Serogodskaya ED, Kalashnikova OV, Ravelli A, Chasnyk VG (2016) Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experience and subgroup analysis in a cohort with frequent methotrexate use. Clin Exp Rheumatol 34(4):714\u2013718","journal-title":"Clin Exp Rheumatol"},{"key":"4702_CR9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/bmj.307.6908.846","volume":"307","author":"BHG Beardon","year":"1993","unstructured":"Beardon BHG, McGilchrist MM, McKendrick AD, McDevitt DG, MacDonald TM (1993) Primary non-compliance with prescribed medication in primary care. BMJ 307:846\u2013848","journal-title":"BMJ"},{"key":"4702_CR10","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/art.30426","volume":"63","author":"E Nordal","year":"2011","unstructured":"Nordal E, Zak M, Aalto K, Berntson L, Fasth A, Herlin T, Lahdenne P, Nielsen S, Straume B, Rygg M, Nordic Study Group of Pediatric Rheumatology (2011) Ongoing disease activity and changing categories in a long-term Nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 63:2809\u20132818","journal-title":"Arthritis Rheum"},{"issue":"6","key":"4702_CR11","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3899\/jrheum.131503","volume":"41","author":"CA Wallace","year":"2014","unstructured":"Wallace CA, Giannini EH, Spalding SJ, Hashkes PJ, O\u2019Neil KM, Zeft AS et al (2014) Childhood Arthritis and Rheumatology Research Alliance (CARRA). Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. J Rheumatol 41(6):1163\u20131170. \nhttps:\/\/doi.org\/10.3899\/jrheum.131503","journal-title":"J Rheumatol"},{"issue":"10072","key":"4702_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(17)30065-X","volume":"389","author":"A Ravelli","year":"2017","unstructured":"Ravelli A, Dav\u00ec S, Bracciolini G, Pistorio A, Consolaro A, van Dijkhuizen EHP, Lattanzi B, Filocamo G, Verazza S, Gerloni V, Gattinara M, Pontikaki I, Insalaco A, de Benedetti F, Civino A, Presta G, Breda L, Marzetti V, Pastore S, Magni-Manzoni S, Maggio MC, Garofalo F, Rigante D, Gattorno M, Malattia C, Picco P, Viola S, Lanni S, Ruperto N, Martini A, Italian Pediatric Rheumatology Study Group (2017) Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trial. Lancet. 389(10072):909\u2013916. \nhttps:\/\/doi.org\/10.1016\/S0140-6736(17)30065-X","journal-title":"Lancet."},{"issue":"1","key":"4702_CR13","first-page":"148","volume":"34","author":"EH van Dijkhuizen","year":"2016","unstructured":"van Dijkhuizen EH, Pouw JN, Scheuern A, Hugle B, Hardt S, Ganser G et al (2016) Methotrexate intolerance in oral and subcutaneous administration in patients with juvenile idiopathic arthritis: a cross-sectional, observational study. Clin Exp Rheumatol 34(1):148\u2013154","journal-title":"Clin Exp Rheumatol"}],"updated-by":[{"DOI":"10.1007\/s10067-019-04821-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04702-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04702-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04702-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T13:08:40Z","timestamp":1600261720000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04702-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4702"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04702-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The first and family names of the authors were interchanged and are now presented correctly. The original article has been corrected.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}